Clinical Trial: Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208617) titled 'Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia' on Sept. 28.

Brief Summary: Based on the Tongren Myopia and Amblyopia Therapeutic Apparatus (a 650nm low-level red-light device) developed by the research team in the previous phase, the device was modified by replacing the light source with LED light. Subsequently, a population study was conducted to evaluate its efficacy and safety in myopia prevention and control.

Study Start Date: Sept. 29

Study Type: INTERVENTIONAL

Condition: Myopia

Intervention: DEVICE: RED-light device using LED light source

The light source ty...